Network News
Danvers, MA, USA, October 7, 2026–Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the availability for purchase of GMP-grade recombinant monoclonal antibody conjugates targeting the G4S linker of scFv-based chimeric antigen receptors (CARs) for CAR-T cell enrichment and detection in cell therapy manufacturing […]
read more
Wittenstein Biointelligence Prize: AwardedBacteria Produce Bioplastic; Living Nerve Cells Process Information
The Wittenstein Biointelligence Prize was awarded on Tuesday evening at the third Biointelligence Congress. Biotechnologist Moritz Bross won in the “Individual” category, while Cortical Labs was honored in the “Company” category. With this prize, the Wittenstein Foundation recognizes innovative, practical, and sustainable solutions that combine biology with information and production technology. Full Text in German […]
read more
European Commission grants €57 million to critical open data resources
Horizon Europe funding will support GENCODE, UniProt, and Europe PMC The European Commission has announced €57 million in funding to support GENCODE, UniProt, and Europe PMC. These life sciences data resources are delivered and managed by EMBL’s European Bioinformatics Institute (EMBL-EBI) alongside international partners. The financial support will be given in the shape of three […]
read more
Harnessing Synthetic Cellular Systems as Immune Cell Boosters
How can cell-based immunotherapies for cancer and autoimmune diseases become more widely available in the long term? The SYNTHIA project is addressing this challenge: The Max Planck Institute for Medical Research and the Fraunhofer Institute for Cell Therapy and Immunology IZI are collaborating on new research approaches to advance the development of cell-based immunotherapies. The […]
read more
Hummingbird Diagnostics to Present Blood-Based RNA Biomarker Data in Stage III Lung Cancer at ESMO 2026
More Information HEIDELBERG, Germany, September 30, 2026 – Hummingbird Diagnostics GmbH, a molecular diagnostics company specializing in blood-based small RNA analysis for precision oncology, today announced that data from a new collaborative study will be presented at the ESMO Congress 2026 in Madrid, Spain. Building on Hummingbird’s expertise in early cancer detection, the study explores […]
read more
Greater Precision and Safety in Neurosurgical Procedures
A new surgical system at the Department of Neurosurgery at Heidelberg University Hospital helps surgeons precisely plan procedures on the brain, spine, and skull base, monitor them during surgery, and perform them with millimeter precision. The “Robotic Surgery Suite,” which cost approximately 1.6 million euros, combines live imaging, digital navigation, and robotic assistance directly in […]
read more
Sarel Fleishman receives the Otto Meyerhof Medal
For his outstanding scientific achievements in the development of new proteins using computer-aided methods, Sarel Fleishman has been awarded the Otto Meyerhof Medal by the Max Planck Institute for Medical Research on September 30, 2026. “I am deeply grateful to the Max Planck Institute for Medical Research for the honor of receiving the Otto Meyerhof […]
read more
Strengthening the Region as a Hub for Technology and Research
Press release of the L-Bank Baden-Württemberg, 28 September 2026 With the official opening of the building at Markwiesenstraße 53 in Reutlingen, the Tübingen-Reutlingen Technology Park continues its success story. Multifunctional spaces for offices, workshops, and laboratories have been created for young technology-based companies and scientific institutions. In the new NMI expansion building at Markwiesenstraße 53-1, […]
read more
BioMed X Launches New Neuroscience Research Team to Investigate Anhedonia
New Haven, CT, USA, September 29, 2026 – BioMed X, a leading innovation engine for pharma, today announced the start of a new research team in collaboration with AbbVie at the BioMed X Institute in New Haven, Connecticut. The new project, entitled “Circuit-Based Model Systems of Anhedonia” (CMA), will be led by BioMed X innovation […]
read more
